B. Riley Issues Negative Estimate for Novavax Earnings
Novavax, Inc. (NASDAQ:NVAX – Free Report) – B. Riley cut their Q1 2025 earnings per share estimates for Novavax in a report issued on Monday, March 3rd. B. Riley analyst M. Mamtani now forecasts that the biopharmaceutical company will post earnings of ($0.46) per share for the quarter, down from their prior forecast of ($0.38). ...
Publicado el: 2025-03-07 06:48:58
Autor: MarketBeat News, Fuente: etfdailynews
Compartir: 
